{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:49:42Z","timestamp":1758815382725},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1996,10,1]],"date-time":"1996-10-01T00:00:00Z","timestamp":844128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[1996,10]]},"DOI":"10.1007\/s004670050183","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T09:09:23Z","timestamp":1030266563000},"page":"651-653","source":"Crossref","is-referenced-by-count":17,"title":["The management of renal osteodystrophy"],"prefix":"10.1007","volume":"10","author":[{"given":"Isidro B.","family":"Salusky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William G.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"60100651467_CR1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","volume":"43","author":"DJ Sherrard","year":"1993","unstructured":"Sherrard DJ, Hercz G, Pei Y, Maloney N, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV (1993) The spectrum of bone disease in end-stage renal failure \u2014 an evolving disorder. Kidney Int 43: 436\u2013442","journal-title":"Kidney Int"},{"key":"60100651467_CR2","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","volume":"47","author":"A Torres","year":"1995","unstructured":"Torres A, Lorenzo V, Hernandez D, Rodriguez JC, Concepcion MT, Rodriguez AP, Hernandez A, De Bonis E, Darias E, Gonzales-Posada JM, Losada M, Rufino M, Felsenfeld AJ, Rodriguez M (1995) Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 47: 1434\u20131442","journal-title":"Kidney Int"},{"key":"60100651467_CR3","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","volume":"46","author":"WG Goodman","year":"1994","unstructured":"Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46: 1160\u20131166","journal-title":"Kidney Int"},{"key":"60100651467_CR4","first-page":"56","volume":"6","author":"DJ Sherrard","year":"1986","unstructured":"Sherrard DJ (1986) Renal osteodystrophy. Semin Nephrol 6: 56\u201367","journal-title":"Semin Nephrol"},{"key":"60100651467_CR5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.1988.96","volume":"33","author":"IB Salusky","year":"1988","unstructured":"Salusky IB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG (1988) Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33: 975\u2013982","journal-title":"Kidney Int"},{"key":"60100651467_CR6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ki.1993.323","volume":"44","author":"G Hercz","year":"1993","unstructured":"Hercz G, Pei Y, Greenwood C, Manuel A, Saiphoo C, Goodman WG, Segre GV, Fenton S, Sherrard DJ (1993) Aplastic osteodystrophy without aluminum: the role of \u201csuppressed\u201d parathyroid function. Kidney Int 44: 860\u2013866","journal-title":"Kidney Int"},{"key":"60100651467_CR7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jbmr.5650100121","volume":"10","author":"Y Pei","year":"1995","unstructured":"Pei Y, Hercz G, Greenwood C, Segre GV, Manuel A, Saiphoo C, Fenton S, Sherrard DJ (1995) Fisk factors for renal osteodystrohpy: a multivariant analysis. J Bone Miner Res 10: 149\u2013156","journal-title":"J Bone Miner Res"},{"key":"60100651467_CR8","first-page":"304","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"WG Goodman","year":"1993","unstructured":"Goodman WG, Coburn JW, Ramirez JA, Slatopolsky E, Salusky IB (1993) Renal osteodystrophy in adult and pediatric patients. In: Favus M (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. Raven, New York, pp 304\u2013323"},{"key":"60100651467_CR9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0022-3476(86)81064-2","volume":"108","author":"IB Salusky","year":"1986","unstructured":"Salusky IB, Coburn JW, Foley J, Nelson P, Fine RN (1986) Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis. J Pediatr 108: 767\u2013770","journal-title":"J Pediatr"},{"key":"60100651467_CR10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199102213240804","volume":"324","author":"IB Salusky","year":"1991","unstructured":"Salusky IB, Foley J, Nelson P, Goodman WG (1991) Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. N Engl J Med 324: 527\u2013531","journal-title":"N Engl J Med"},{"key":"60100651467_CR11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000420142","volume":"90","author":"WG Goodman","year":"1991","unstructured":"Goodman WG, Salusky IB (1991) Evolution of secondary hyperparathyroidism during daily oral calcitriol therapy in pediatric renal osteodystrophy. Contrib Nephrol 90: 189\u2013195","journal-title":"Contrib Nephrol"},{"key":"60100651467_CR12","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","volume":"74","author":"E Slatopolsky","year":"1984","unstructured":"Slatopolsky E, Weerts C, Thielan J, Horst RL, Harter H, Martin KJ (1984) Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74: 2136\u20132143","journal-title":"J Clin Invest"},{"key":"60100651467_CR13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/ki.1987.68","volume":"31","author":"JA Delmez","year":"1987","unstructured":"Delmez JA, Dougan CS, Gearing BK, Rothstein M, Windus DW, Rapp N, Slatopolsky E (1987) The effects of intraperitoneal calcitriol on calcium and parathyroid hormone. Kidney Int 31:795\u2013799","journal-title":"Kidney Int"},{"key":"60100651467_CR14","first-page":"421","volume":"315","author":"M Fukagawa","year":"1990","unstructured":"Fukagawa M, Kitaoka M, Kaname S, Okazaki R, Matsumoto T, Ogata E, Hoshino M, Inada T, Sekine T, Kurokawa K (1990) Suppression of parathyroid gland hyperplasia by l,25(OH)2D3 pulse therapy. N Engl J Med 315: 421\u2013422","journal-title":"N Engl J Med"},{"key":"60100651467_CR15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/ki.1993.377","volume":"44","author":"H Reichel","year":"1993","unstructured":"Reichel H, Szabo A, Uhl J, Pesian S, Schmutz A, Schmidt-Gayk H, Ritz E (1993) Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism. Kidney Int 44: 1259\u20131265","journal-title":"Kidney Int"},{"key":"60100651467_CR16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","volume":"321","author":"DL Andress","year":"1989","unstructured":"Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ (1989) Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321: 274\u2013279","journal-title":"N Engl J Med"},{"key":"60100651467_CR17","first-page":"122","volume":"20","author":"S Mazzaferro","year":"1994","unstructured":"Mazzaferro S, Pasquali M, Ballanti P, Bonucci E, Di Sanza P, Sardella D, Taggi F, Coen G (1994) Intravenous versus oral calcitriol therapy in renal osteodystrophy: results of a prospective, pulsed and dose-comparable study. Miner Electrolyte Metab 20: 122\u2013129","journal-title":"Miner Electrolyte Metab"},{"key":"60100651467_CR18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ki.1994.31","volume":"45","author":"IB Salusky","year":"1994","unstructured":"Salusky IB, Ramirez JA, Oppenheim WL, Gales B, Segre GV, Goodman WG (1994) Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD\/CCPD. Kidney Int 45: 253\u2013258","journal-title":"Kidney Int"},{"key":"60100651467_CR19","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/ki.1989.309","volume":"36","author":"A Lefebvre","year":"1989","unstructured":"Lefebvre A, Vernejoul MC de, Gueris J, Goldfarb B, Graulet AM, Morieux C (1989) Optimal correction of acidosis changes progression of dialysis osteodytrophy. Kidney Int 36: 1112\u20131118","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s004670050183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s004670050183\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s004670050183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:03:32Z","timestamp":1559091812000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s004670050183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,10]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,10]]}},"alternative-id":["60100651467"],"URL":"https:\/\/doi.org\/10.1007\/s004670050183","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,10]]}}}